Gemmer Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-45	Closed	-$3K	–	667
2022 Q1	$3K	Buy	45 +8	+22%	+$533	﹤0.01%	1086
2021 Q4	$4K	Hold	37	–	–	﹤0.01%	1062
2021 Q3	$3K	Hold	37	–	–	﹤0.01%	1129
2021 Q2	$3K	Hold	37	–	–	﹤0.01%	1302
2021 Q1	$4K	Hold	37	–	–	﹤0.01%	1157
2020 Q4	$2K	Hold	37	–	–	﹤0.01%	1329
2020 Q3	$2K	Hold	37	–	–	﹤0.01%	1195
2020 Q2	$3K	Hold	37	–	–	﹤0.01%	1049
2020 Q1	$2K	Sell	37 -3	-8%	-$162	﹤0.01%	1079
2019 Q4	$3K	Hold	40	–	–	﹤0.01%	1145
2019 Q3	$2K	Hold	40	–	–	﹤0.01%	1251
2019 Q2	$3K	Sell	40 -45	-53%	-$3.38K	﹤0.01%	1129
2019 Q1	$7K	Hold	85	–	–	﹤0.01%	850
2018 Q4	$7K	Hold	85	–	–	﹤0.01%	773
2018 Q3	$15K	Hold	85	–	–	﹤0.01%	508
2018 Q2	$11K	Hold	85	–	–	﹤0.01%	658
2018 Q1	$9K	Hold	85	–	–	﹤0.01%	734
2017 Q4	$7K	Hold	85	–	–	﹤0.01%	841
2017 Q3	$7K	Hold	85	–	–	﹤0.01%	815
2017 Q2	$6K	Buy	85 +2	+2%	+$141	﹤0.01%	862
2017 Q1	$6K	Buy	83 +1	+1%	+$72	﹤0.01%	868
2016 Q4	$5K	Hold	82	–	–	﹤0.01%	902
2016 Q3	$5K	Hold	82	–	–	﹤0.01%	897
2016 Q2	$6K	Hold	82	–	–	﹤0.01%	789
2016 Q1	$5K	Buy	82 +45	+122%	+$2.74K	﹤0.01%	823
2015 Q4	$2K	Hold	37	–	–	﹤0.01%	1120
2015 Q3	$2K	Buy	37 +16	+76%	+$865	﹤0.01%	1096
2015 Q2	$1K	Buy	21 +5	+31%	+$238	﹤0.01%	1253
2015 Q1	$1K	Sell	16 -8	-33%	-$500	﹤0.01%	1291
2014 Q4	$1K	Sell	24 -16	-40%	-$667	﹤0.01%	1286
2014 Q3	$1K	Sell	40 -6	-13%	-$150	﹤0.01%	1282
2014 Q2	$2K	Buy	46 +12	+35%	+$522	﹤0.01%	1177
2014 Q1	$1K	Buy	+34	New	+$1K	﹤0.01%	1292